Celecoxib composition, and preparation method and use thereof
A technology of celecoxib and composition, which is applied in the field of celecoxib composition, preparation and use, and can solve the problems of increased tablet hardness and the like
Inactive Publication Date: 2013-03-06
TIANJIN INSTITUTE OF PHARMA RESEARCH
View PDF3 Cites 15 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0013] (5), the hardness of tablet increases;
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0072] Capsules are prepared with the following composition:
[0073]
[0074]
Embodiment 2
[0076] Capsules are prepared with the following composition:
[0077]
Embodiment 3
[0079] Capsules are prepared with the following composition:
[0080]
[0081]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Login to View More
Abstract
The invention provides a celecoxib composition. The celecoxib composition contains one or more types of dose units which can be orally released, and each of the dose units contains 50-500mg of celecoxib D95 particles and one or more types of mixtures of pharmaceutical excipients. The composition can be used for treating or preventing diseases caused by COX-2.
Description
technical field [0001] The present invention relates to an orally releasable pharmaceutical composition containing active ingredient celecoxib (celecoxib, trade name Celebrex), a method for preparing the composition, and a method for treating cyclooxygenase-2 (COX-2)-induced A method for diseases, said method comprising orally administering said composition to a patient, and the use of said composition in the manufacture of a medicament. Background technique [0002] In 1994, G.D Searle Company of the United States applied for a patent in China, the patent number was CN1141630, and the compound 4-[5-(4-methylphenyl-3-(trifluoromethyl-1H-pyrazole-1) was once reported in the patent -yl] benzenesulfonamide (celecoxib), this patent describes and claims a class of 1,5-diarylpyrazoles and salts thereof and the method for preparing said compound. Celecoxib has the following structure: [0003] [0004] It is reported in CN1141630 that the compound can be used to treat inflammat...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): A61K31/635A61P19/04A61P29/00A61P19/02A61P9/00A61P9/10
Inventor 梅林雨罗振福梁忠信郑志超高晶靳朝东张晓东
Owner TIANJIN INSTITUTE OF PHARMA RESEARCH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com